Yasmeen Niazi

Dr. Yasmeen Niazi

DKFZ, Heidelberg, Baden-Württemberg, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 May 2022 in Blood Cancer Journal
Verified
Journal Article
Open access
PDF file
PGPaloma García-Martín
Paloma García-Martín
ADAna Moñiz Díez
Ana Moñiz Díez
JMJosé Manuel Sánchez Maldonado
José Manuel Sánchez Maldonado
ASAntonio José Cabrera Serrano
Antonio José Cabrera Serrano
RHRob ter Horst
Rob ter Horst
Juan SainzJuan Sainz
Juan Sainz

16 June 2021 in Frontiers in Genetics
Verified
Journal Article
Open access
PDF file
YNYasmeen Niazi
Yasmeen Niazi
Hauke ThomsenHauke Thomsen
Hauke Thomsen
BSBozena Smolkova
Bozena Smolkova
LVLudmila Vodickova
Ludmila Vodickova
SVSona Vodenkova
Sona Vodenkova
AFAsta Försti
Asta Försti
DNA damage and unrepaired or insufficiently repaired DNA double-strand breaks as well as telomere shortening contribute to the formation of structural chromosomal aberrations (CAs). Non-specific CAs have been used in the monitoring of individuals exposed to potential carcinogenic chemicals and radiation. The frequency of CAs in peripheral blood lymphocytes (PBLs) has been associated with cancer risk and the association has also been found in incident cancer patients. CAs include chromosome-type aberrations (CSAs) and chromatid-type aberrations (CTAs) and their sum CAtot. In the present study, we used data from our published genome-wide association studies (GWASs) and extracted the results for 153 DNA repair genes for 607 persons who had occupational exposure to diverse harmful substances/radiation and/or personal exposure to tobacco smoking. The analyses were conducted using linear and logistic regression models to study the association of DNA repair gene polymorphisms with CAs. Considering an arbitrary cutoff level of 5 × 10–3, 14 loci passed the threshold, and included 7 repair pathways for CTA, 4 for CSA, and 3 for CAtot; 10 SNPs were eQTLs influencing the expression of the target repair gene. For the base excision repair pathway, the implicated genes PARP1 and PARP2 encode poly(ADP-ribosyl) transferases with multiple regulatory functions. PARP1 and PARP2 have an important role in maintaining genome stability through diverse mechanisms. Other candidate genes with known roles for CSAs included GTF2H (general transcription factor IIH subunits 4 and 5), Fanconi anemia pathway genes, and PMS2, a mismatch repair gene. The present results suggest pathways with mechanistic rationale for the formation of CAs and emphasize the need to further develop techniques for measuring individual sensitivity to genotoxic exposure.

3 October 2018 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Closed access
PDF file
YNYasmeen Niazi
Yasmeen Niazi
Hauke ThomsenHauke Thomsen
Hauke Thomsen
Božena SmolkováBožena Smolková
Božena Smolková
LVLudmila Vodickova
Ludmila Vodickova
SVSona Vodenkova
Sona Vodenkova
AFAsta Försti
Asta Försti

26 December 2022 in Cells
Verified
Journal Article
Open access
PDF file
YNYasmeen Niazi
Yasmeen Niazi
NPNagarajan Paramasivam
Nagarajan Paramasivam
JBJoanna Blocka
Joanna Blocka
AAAbhishek A0bhishek
Abhishek A0bhishek
SHStefanie Huhn
Stefanie Huhn
Asta FörstiAsta Försti
Asta Försti
Multiple myeloma (MM) is a plasma cell malignancy whereby a single clone of plasma cells over-propagates in the bone marrow, resulting in the increased production of monoclonal immunoglobulin. While the complex genetic architecture of MM is well characterized, much less is known about germline variants predisposing to MM. Genome-wide sequencing approaches in MM families have started to identify rare high-penetrance coding risk alleles. In addition, genome-wide association studies have discovered several common low-penetrance risk alleles, which are mainly located in the non-coding genome. Here, we further explored the genetic basis in familial MM within the non-coding genome in whole-genome sequencing data. We prioritized and characterized 150 upstream, 5′ untranslated region (UTR) and 3′ UTR variants from 14 MM families, including 20 top-scoring variants. These variants confirmed previously implicated biological pathways in MM development. Most importantly, protein network and pathway enrichment analyses also identified 10 genes involved in mitogen-activated protein kinase (MAPK) signaling pathways, which have previously been established as important MM pathways.

16 July 2020 in Blood Cancer Journal
Verified
Journal Article
Open access
PDF file
JSJ. M. Sánchez-Maldonado
J. M. Sánchez-Maldonado
DCD. Campa
D. Campa
JSJ. Springer
J. Springer
JBJ. Badiola
J. Badiola
YNYasmeen Niazi
Yasmeen Niazi
Juan SainzJuan Sainz
Juan Sainz
The purpose of this study was to conduct a two-stage case control association study including 654 acute myeloid leukaemia (AML) patients and 3477 controls ascertained through the NuCLEAR consortium to evaluate the effect of 27 immune-related single nucleotide polymorphisms (SNPs) on AML risk. In a pooled analysis of cohort studies, we found that carriers of the IL13rs1295686A/A genotype had an increased risk of AML (PCorr = 0.0144) whereas carriers of the VEGFArs25648T allele had a decreased risk of developing the disease (PCorr = 0.00086). In addition, we found an association of the IL8rs2227307 SNP with a decreased risk of developing AML that remained marginally significant after multiple testing (PCorr = 0.072). Functional experiments suggested that the effect of the IL13rs1295686 SNP on AML risk might be explained by its role in regulating IL1Ra secretion that modulates AML blast proliferation. Likewise, the protective effect of the IL8rs2227307 SNP might be mediated by TLR2-mediated immune responses that affect AML blast viability, proliferation and chemorresistance. Despite the potential interest of these results, additional functional studies are still warranted to unravel the mechanisms by which these variants modulate the risk of AML. These findings suggested that IL13, VEGFA and IL8 SNPs play a role in modulating AML risk.

1 July 2019 in Mutagenesis
Verified
Journal Article
Closed access
YNYasmeen Niazi
Yasmeen Niazi
Hauke ThomsenHauke Thomsen
Hauke Thomsen
Božena SmolkováBožena Smolková
Božena Smolková
LVLudmila Vodickova
Ludmila Vodickova
SVSoňa Vodenkova
Soňa Vodenkova
AFAsta Försti
Asta Försti
Non-specific structural chromosomal aberrations (CAs) observed in peripheral blood lymphocytes of healthy individuals can be either chromosome-type aberrations (CSAs) or chromatid-type aberrations (CTAs) depending on the stage of cell division they are induced in and mechanism of formation. It is important to study the genetic basis of chromosomal instability as it is a marker of genotoxic exposure and a predictor of cancer risk. For that purpose, we conducted two genome-wide association studies (GWASs) on healthy individuals in the presence and absence of apparent genotoxic exposure from the Czech Republic and Slovakia. The pre-GWAS cytogenetic analysis reported the frequencies of CSA, CTA and total CA (CAtot). We performed both linear and binary logistic regression analysis with an arbitrary cut-off point of 2% for CAtot and 1% for CSA and CTA. Using the statistical threshold of 1.0 × 10−5, we identified five loci with in silico predicted functionality in the reference group and four loci in the exposed group, with no overlap between the associated regions. A meta-analysis on the two GWASs identified further four loci with moderate associations in each of the studies. From the reference group mainly loci within genes related to DNA damage response/repair were identified. Other loci identified from both the reference and exposed groups were found to be involved in the segregation of chromosomes and chromatin modification. Some of the discovered regions in each group were implicated in tumourigenesis and autism.